What diabetes medicine sitagliptin going off patent means for prices - The Indian Express

A reduction in price of generic versions of the diabetes medicine is expected to affect more than 70 million diabetes patients in India

With the diabetes medicine sitagliptin going out of patent, many pharmaceutical companies have jumped on the chance to market generic versions of the druga move likely to bring down the price of the … [+5111 chars]

full article...